Followers | 839 |
Posts | 120487 |
Boards Moderated | 18 |
Alias Born | 09/05/2002 |
Monday, December 23, 2019 3:23:55 PM
https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-adults-migraine
Ubrelvy may do well in the crowded CGRP arena because it’s oral.
AGN has a second oral CGRP candidate, Atogepant, in development for migraine prevention.
AGN acquired both drugs from MRK in 2015 for what now appears to be a very reasonable price (#msg-115206907).
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM